SCHEMBL1998376

SCHEMBL1998376

C[Si](C)(/C=C/c1ccccc1)c1ccccc1CO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3G Q9HC16 1/20 0.36
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
GLA P06280 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GRM5 P41594 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
CYP2D6 P10635 2/20 0.33
NR1I2 O75469 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2C P18825 1/20 0.33
CNR1 P21554 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2A P28223 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRK1 P41145 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998378 1.00 APOBEC3G (0.36) APOBEC3GPDCD1CD274GLATDP1
SCHEMBL2004175 0.81 APOBEC3G (0.39) APOBEC3GPDCD1CD274MEN1KMT2A
SCHEMBL2004176 0.81 APOBEC3G (0.39) APOBEC3GPDCD1CD274MEN1KMT2A
SCHEMBL2007121 0.75 APOBEC3G (0.41) APOBEC3GPDCD1CD274MEN1KMT2A
SCHEMBL2006118 0.74 APOBEC3G (0.39) APOBEC3GPDCD1CD274MEN1KMT2A
SCHEMBL9206225 0.72 APOBEC3G (0.48) APOBEC3GPDCD1CD274MEN1KMT2A
SCHEMBL2004591 0.71 FAAH (0.39) CNR1
SCHEMBL2004589 0.71 FAAH (0.39) CNR1
SCHEMBL9226489 0.70 MAOB (0.44) GLATDP1GRM5MEN1KMT2A
SCHEMBL8159137 0.70 MAOB (0.44) GLATDP1GRM5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960571-B2 Silicon-based cross-coupling reagent and production method of organic compound using the same KYOTO UNIVERSITY (JP) 2011-06-14 US disclosed
US-7960571-B2 Silicon-based cross-coupling reagent and production method of organic compound using the same KYOTO UNIVERSITY (JP) 2011-06-14 US disclosed
US-20090069577-A1 Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same KYOTO UNIVERSITY (JP) 2009-03-12 US disclosed
US-20090069577-A1 Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same KYOTO UNIVERSITY (JP) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069577-A1 Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same DNMT1, TET3, CTCF APOBEC3G 3259/4885PDCD1 4654/4885CD274 4802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.